Animal models for experimental tuberculosis

Clinical Infectious Diseases

Volumn 31, Issue , 2000, Pages S68-S70

  Smith, D ^a   Wiegeshaus, E ^a   Balasubramanian, V ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; LIVE VACCINE;

ANIMAL MODEL; CONFERENCE PAPER; DISEASE COURSE; NEBULIZER; NONHUMAN; PRIORITY JOURNAL; SAFETY; TUBERCULOSIS; VACCINE PRODUCTION;

ANIMALS; BACTERIAL VACCINES; BCG VACCINE; DISEASE MODELS, ANIMAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VACCINES, ATTENUATED;

EID: 0034453834     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/314071     Document Type: Article

References (13)

1. Non-living immunogenic substances of mycobacteria
2. Evaluation of the protective potency of new tuberculosis vaccines
3. Models for potency assay of tuberculosis vaccines
4. Immunity to tuberculosis from the perspective of pathogenesis
5. Immunological aspects of airborne infection: Reactions to inhaled antigens
6. Host-parasite relationships in experimental airborne tuberculosis. III. Relevance of microbial enumeration to acquired cellular resistance in guinea pigs
7. Notes on the particle size output of Collison Nebulizers
8. Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia
9. Host parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70 centigrade
10. Pathogenesis of tuberculosis: Pathway to apical localization
11. The natural history of tuberculosis in man
12. Host-parasite relationships in experimental airborne tuberculosis. V. Lack of hematogenous dissemination to the lungs in animals vaccinated with bacille Calmette-Guérin
13. BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route